The
research report “Cancer Gene Therapy
Market Size By Type [Gene Induced
Immunotherapy (Cytokine Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic
Virotherapy (Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus,
Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus), Gene Transfer/Gene
Replacement (Naked/Plasmid Vectors, Electroporation, Sonoporation,
Magnetofection, Gene Gun)], Industry Analysis Report, Regional Outlook (U.S.,
Canada, UK, Germany, China, Japan, Mexico, Brazil, South Africa, Saudi Arabia),
Application Potential, Price Trends, Competitive Market Share & Forecast,
2016 – 2024”,
by Global Market Insights, Inc., says Cancer gene therapy industry revenue,
which was assessed at USD 805.5 million in 2015, is projected to hit USD 4.3
billion by 2024.
A
significant rise in the number of cancer incidences has led to the deployment
of genome technologies, which will spur Cancer Gene Therapy Market size. As per
WHO estimates, the number of cancer cases is estimated to increase by 70% over
the coming two decades, which will stimulate the introduction of new gene
therapies. Heavy funding by the government for cancer research programs and
beneficial schemes favoring cancer screening programs are expected to produce
lucrative avenues for cancer gene therapy market.
The
differentiating factor of Cancer Gene Therapy market report by Global Market
Insights, Inc. when compared with other, similar syndicated research studies
includes a 360-degree synopsis of trends for a period of more than 10 years
including historic information as well as future outlook. Business focussed
multiple trends for Cancer Gene Therapy industry are discussed along with
regional trends to offer an overall view of the market. The ‘industry insights’
chapter of this research provides the most comprehensive analysis of Cancer
Gene Therapy market covering segmentation, size, forecasts, ecosystem analysis
and more. Industry impact forces (regional and global) that cover growth
drivers and challenges, growth potential analysis, a strategy dashboard for
competitive landscape of Cancer Gene Therapy market support this sector specific data and information points.
Order This Report by calling Global Market Insights, Inc.
at 1-888-689-0688 (Toll Free) or 1-302-846-7766.
Considering the regional trends, cancer gene therapy
industry in China, which accounted for 35% of Asia Pacific cancer gene therapy
market share in 2015, is projected to record a CAGR of 21% over the next few
years, having collected a revenue of USD 99.6 million in 2015. Rapid
commercialization of drugs required for cancer gene therapy coupled with
enhanced developments in healthcare services will drive the regional expansion. UK cancer gene therapy industry,
which was assessed at USD 92 million in 2015, is set to grow at an annual rate
of 20.8% over the coming seven years, subject to high frequency of cancer among
the nations’ population along with the acceptance of modern treatment
methodologies. Cancer gene therapy market in Japan, worth USD 78.2
million in 2015, is projected to expand at a CAGR of 20.9% over the period from
2016 to 2024.
Browse
key industry insights spread across 105 pages with 125 market data tables &
6 figures & charts from this 2017 report Cancer Gene Therapy Market in detail along with the table of
contents at:
U.S. cancer gene therapy industry, which contributed more
than 95% of North America cancer gene therapy market revenue in 2015, is
projected to grow at a rate of 20.9% over the coming seven years. It had
amassed an income of USD 235 million in 2015. Innovation in biotechnology and
the rising acceptance of new gene technologies for cancer treatments is
expected to boost the regional revenue.
Cancer
gene therapies comprise gene transfer, oncolytic virotherapy, and gene induced
immunotherapy. Gene transfer market size, which accounted for more than 46% of
the cancer gene therapy market revenue in 2015, is projected to record a CAGR
of 20.9% over the coming timeframe. This therapy helps to permanently alter the
nuclear genome of the host cell and is widely deployed across the medical
sector, stimulating the overall market.
Gene
induced immunotherapy industry, which contributed to 14% of cancer gene therapy
market share in 2015, is slated to surpass USD 592.7 million by 2024. The
growth can be attributed to its ability to effectively fight cancer cells
through new gene insertion in the tumors.
Global
cancer gene therapy market is highly fragmented with small biotech firms
holding a chunk of the overall industry share. Key business expansion
strategies such as deployment of advanced technologies, copyrights &
patenting of products, strategic collaborations, and joint ventures adopted by
major industry participants will help them in retaining their positions in the
global business space. NewLink Genetics Corporation, ZIOPHARM Oncology
Incorporation, Shenzhen Sibiono GeneTech Company Limited, Genelux Corporation,
Gradalis Incorporation, Altor Bioscience Corporation, Shanghai Sunway Biotech
Company Limited, Amgenen Incorporation, MultiVir Incorporation, Aduro Biotech
Incorporation, OncoGeneX Pharmaceuticals Company, GlobeImmune Incorporation,
MolMed S.p.A., and BioCancell Therapeutic Incorporation are the few of the
established players of cancer gene therapy industry.
Cancer Biological Therapy
Market Size By Product (Monoclonal Antibodies [Naked Monoclonal
Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal
Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers
[Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood
Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons,
Interleukins]), Industry Analysis Report, Regional Outlook, Application
Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
About Global Market Insights"
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and
actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment